1. Home
  2. AXGN vs BCRX Comparison

AXGN vs BCRX Comparison

Compare AXGN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$33.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$6.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
BCRX
Founded
N/A
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
AXGN
BCRX
Price
$33.29
$6.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$33.67
$20.82
AVG Volume (30 Days)
1.0M
4.3M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$214,709,000.00
$599,816,000.00
Revenue This Year
$21.98
$40.21
Revenue Next Year
$15.61
$6.13
P/E Ratio
N/A
N/A
Revenue Growth
18.72
45.38
52 Week Low
$9.22
$6.00
52 Week High
$36.00
$11.31

Technical Indicators

Market Signals
Indicator
AXGN
BCRX
Relative Strength Index (RSI) 49.68 51.18
Support Level $30.98 $6.26
Resistance Level $35.65 $6.91
Average True Range (ATR) 1.70 0.26
MACD -0.27 0.06
Stochastic Oscillator 43.43 85.92

Price Performance

Historical Comparison
AXGN
BCRX

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: